Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/6935 stock hub

TPEX/6935 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6935is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6935

In the news

Latest news · TPEX/6935

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E11.9

P25 14.4P50 18P75 31.9

ROE12.3

P25 -16.2P50 0.3P75 9.8

ROIC9.2

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6935 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

TWD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	216
Employees Change	6%
Employees Change Percent	2.86
Enterprise value	TWD 1.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0006935000
Last refreshed	2026-05-10
Market cap	TWD 1.1B
Price	TWD 30.5
Price currency	TWD
Rev Per Employee	4,889,819.44x
Sector	Healthcare
Sic	2834
Symbol	tpex/6935
Website	https://www.prince-pharm.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.5%
EV Earnings	14.56x
EV/EBIT	12.65x
EV/EBITDA	8.13x
EV/FCF	19.53x
EV/Sales	1.33x
FCF yield	6.34%
P/B ratio	1.35x
P/E ratio	11.86x
P/S ratio	1.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.5%
EBITDA Margin	15.49%
FCF margin	6.8%
Gross margin	21.07%
Gross Profit	TWD 222.6M
Gross Profit Growth	90.32%
Gross Profit Growth Q	289.42%
Gross Profit Growth3 Y	21.99%
Gross Profit Growth5 Y	7.55%
Net Income	TWD 96.3M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth5 Y	32.2%
Pretax Margin	9.92%
Profit Margin	9.12%
Profit Per Employee	TWD 445,931
Profitable Years	1
ROA	4.86
Roa5y	1.4
ROCE	9.29
ROE	12.34
Roe5y	2.83
ROIC	9.2
Roic5y	2.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	49.55%
Cagr3y	-13.82%
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth5 Y	30.31
FCF Growth	154.56%
FCF Growth Q	122.38%
FCF Growth3 Y	65.87%
FCF Growth5 Y	14.85%
OCF Growth	94.9%
OCF Growth Q	120.15%
OCF Growth3 Y	11.41%
OCF Growth5 Y	6.37%
Revenue Growth	53.07x
Revenue Growth Q	73.65x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	12.74x
Revenue Growth5 Y	8.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.74
Assets	TWD 1.5B
Cash	TWD 152.6M
Current Assets	TWD 560.9M
Current Liabilities	TWD 309.9M
Debt	TWD 422M
Debt EBITDA	TWD 2.45
Debt Equity	TWD 0.5
Debt FCF	TWD 5.88
Equity	TWD 838.7M
Interest Coverage	11.57
Liabilities	TWD 664.8M
Long Term Assets	TWD 942.6M
Long Term Liabilities	TWD 354.9M
Net Cash	TWD -269.4M
Net Cash By Market Cap	TWD -23.78
Net Debt EBITDA	TWD 1.65
Net Debt Equity	TWD 0.32
Net Debt FCF	TWD 3.75
Tangible Book Value	TWD 838.2M
Tangible Book Value Per Share	TWD 22.9
WACC	6.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.81
Inventory Turnover	4.78
Net Working Capital	TWD 166.4M
Quick ratio	1.13
Working Capital	TWD 251M
Working Capital Turnover	TWD 5.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.03%
Dividend per share	TWD 0
Last Dividend	TWD 0.25

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	49.51%
200-day SMA	29.26
3Y total return	-36.01%
50-day SMA	28.99
50-day SMA vs 200-day SMA	50under200
All Time High	75.2
All Time High Change	-59.44%
All Time High Date	2023-03-30
All Time Low	18.5
All Time Low Change	64.86%
All Time Low Date	2025-04-09
ATR	1.27
Beta	0.72
Beta1y	0.2
Beta2y	0.26
Ch YTD	-1.93
High	31.5
High52	35.85
High52 Date	2025-09-26
High52ch	-14.92%
Low	30
Low52	20.3
Low52 Date	2025-06-02
Low52ch	50.25%
Ma50ch	5.19%
Price vs 200-day SMA	4.25%
RSI	56.11
RSI Monthly	47.65
RSI Weekly	55.81
Sharpe ratio	0.94x
Sortino ratio	1.76
Total Return	-1.03%
Tr YTD	-1.93
Tr1m	8.54%
Tr1w	1.67%
Tr3m	2.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 110.9M
Operating Income Growth	4,646
Operating Income Growth5 Y	26.37
Operating margin	10.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,429,069%
Net Borrowing	-40,506,000
Shares Insiders	5.77%
Shares Institutions	12.5%
Shares Out	36,605,000
Shares Qo Q	1.65%
Shares Yo Y	1.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 70.9M
Average Volume	75,430.95x
Bv Per Share	22.91
CAPEX	TWD -18.2M
Ch1m	8.54
Ch1w	1.67
Ch1y	49.51
Ch3m	2.01
Ch3y	-36.85
Ch6m	-1.61
Change	-2.24%
Change From Open	1.33
Close	31.2
Days Gap	-3.53
Depreciation Amortization	52,736,000
Dollar Volume	1,898,625
Earnings Date	2026-05-12
EBIT	TWD 110.9M
EBITDA	TWD 163.6M
EPS	TWD 2.61
F Score	7
FCF	TWD 71.8M
FCF EV Yield	5.12x
FCF Per Share	TWD 1.96
Financing CF	-20,703,000
Fiscal Year End	December
Founded	1,962
Graham Number	36.68075
Graham Upside	20.26
Income Tax	TWD 8.4M
Investing CF	-19,540,000
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Lynch Fair Value	TWD 65.25
Lynch Upside	113.9
Ma150	30.36
Ma150ch	0.48%
Ma20	30.18
Ma20ch	1.05%
Net CF	49,814,000
Next Earnings Date	2026-05-12
Open	30.1
P FCF Ratio	15.78
P OCF Ratio	12.58
Position In Range	33.33
Ppne	932,723,000
Price Date	2026-05-08
Price EBITDA	TWD 6.92
Ptbv Ratio	1.35
Relative Volume	0.85x
Revenue	1,056,201,000x
SBC By Revenue	0.09x
Share Based Comp	907,000
Tax By Revenue	0.8x
Tax Rate	8.04%
Tr6m	-1.61%
Volume	62,250
Z Score	2.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6935 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6935 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6935?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.5%

Share of float held by funds and institutions

Insider ownership

+5.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.0%

Negative means the company is buying back shares.

Technical

TPEX/6935 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.1

Neutral momentum band

Price vs 200-day MA

+4.3%

50/200-day relationship not available

Beta (5Y)

0.72

Less volatile than the market

Sharpe ratio

0.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6935

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6935 stock rating?

tpex/6935 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6935 analysis?

The full report lives at /stocks/tpex/6935/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6935?

The latest report frames tpex/6935 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6935 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.